Promosome licenses and employs synthetic biology tools which increase protein production yields, enhance purity and likely provide long-term clinical benefits.
Promosome specializes in innovative technologies related to the translation component of protein production. Its products boost production capacity by increasing expression, secretion, and yield of full-length proteins as well as by enhancing downstream efficiencies. It generates revenues from license fees, milestones and royalty arrangements. Promosome has developed a portfolio of therapeutic products (nucleic acid therapeutics, re-engineered hard-to-express proteins, and biosimilars/biobetters) which are available for partnering and commercialization.